High Levels of Soluble Lectinlike Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke

Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes

(2018) Raffaele Ornello et al.   STROKE

Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases

(2018) Anja Hofmann et al.   VASCULAR PHARMACOLOGY

Atherosclerotic plaque vulnerability in the statin era

(2017) Jan Nilsson   EUROPEAN HEART JOURNAL

LOX-1: A potential target for therapy in atherosclerosis; an in vitro study

(2017) Albina Arjuman et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

LOX-1 in Atherosclerosis and Myocardial Ischemia

(2017) Naga Venkata K. Pothineni et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sphingolipids Contribute to Human Atherosclerotic Plaque InflammationHighlights

(2016) Andreas Edsfeldt et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study

(2016) Chiaki Yokota et al.   Journal of Atherosclerosis and Thrombosis

Cross-talk between LOX-1 and PCSK9 in vascular tissues

(2015) Zufeng Ding et al.   CARDIOVASCULAR RESEARCH

Inflammation and plaque vulnerability

(2015) G. K. Hansson et al.   JOURNAL OF INTERNAL MEDICINE

Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway

(2014) Dan Hong et al.   ATHEROSCLEROSIS

Treatment with betablockers is associated with higher grey-scale median in carotid plaques

(2014) Giuseppe Asciutto et al.   BMC Cardiovascular Disorders

LOX-1 Deletion Limits Cardiac Angiogenesis in Mice Given Angiotensin II

(2014) Xianwei Wang et al.   CARDIOVASCULAR DRUGS AND THERAPY

Mechanisms of Plaque Formation and Rupture

(2014) Jacob Fog Bentzon et al.   CIRCULATION RESEARCH

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases

(2013) Angela Pirillo et al.   DISEASE MARKERS

Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans

(2013) Peter Libby et al.   IMMUNITY

Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: Verification by optical coherence tomography

(2013) Nobuaki Kobayashi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy

(2013) Peter Libby   NEW ENGLAND JOURNAL OF MEDICINE

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

(2012) Suowen Xu et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Update on acute coronary syndromes: the pathologists' view

(2012) Erling Falk et al.   EUROPEAN HEART JOURNAL

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

Circulating Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Associated With Angiographic Coronary Lesion Complexity in Patients With Coronary Artery Disease

(2011) Zi-Wen Zhao et al.   CLINICAL CARDIOLOGY

Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease

(2011) Mehmet Balın et al.   Clinical Research in Cardiology

The role of ADAM-mediated shedding in vascular biology

(2011) Daniela Dreymueller et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

The Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and its Soluble Form: Cardiovascular Implications

(2011) Teresa Navarra et al.   Journal of Atherosclerosis and Thrombosis

OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling

(2010) Sungwoo Ryoo et al.   ATHEROSCLEROSIS

LOX Index, a Novel Predictive Biochemical Marker for Coronary Heart Disease and Stroke

(2010) N. Inoue et al.   CLINICAL CHEMISTRY

Interleukin 18 stimulates release of soluble lectin-like oxidized LDL receptor-1 (sLOX-1)

(2008) Hirokazu Mitsuoka et al.   ATHEROSCLEROSIS

The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells

(2008) Ling Li et al.   ATHEROSCLEROSIS

LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet

(2008) C. Hu et al.   CARDIOVASCULAR RESEARCH